APA Citatie

Huang, S., Yang, H., Huang, W., Chen, W., Yu, M., Wang, S., . . . Hsu, M. (2019). WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through p38mapk-p53-survivin Signaling Cascade. Front Oncol.

Chicago Style citaat

Huang, Shiu-Wen, Hung-Yu Yang, Wei-Jan Huang, Wei-Chuan Chen, Meng-Chieh Yu, Shih-Wei Wang, Ya-Fen Hsu, en Ming-Jen Hsu. "WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through P38mapk-p53-survivin Signaling Cascade." Front Oncol 2019.

MLA citatie

Huang, Shiu-Wen, et al. "WMJ-S-001, a Novel Aliphatic Hydroxamate-Based Compound, Suppresses Lymphangiogenesis Through P38mapk-p53-survivin Signaling Cascade." Front Oncol 2019.